KnowTheStock
Log inCreate free account

REVVITY, INC.

RVTY
S&P 500Laboratory Analytical Instruments · NYSE
$113.76last close · market cap 12.70 Billion
Compare with…
43.4SCORE / 100
Our verdictSELLModerate Growth but Declining, Stock Price Very HighQtr Ending 2026-07-05 · trend negative

Why Sell

Income statement, balance sheet and cash flow are moderate.

Next earnings: 2026-11-03 (BMO), EPS Forecast: $1.29

What is strong
  • Debt Ratio is 0.4
  • Total Debt to Total Assets Ratio is 0.22
  • Capital Expenditure is Low
  • Net Increase in Cash is Positive
What to watch
  • Revenue Growth is 4.05%
  • Operating Income Growth is -5.54%
  • Net Income Growth is -16.71%
  • Earnings Per Share (EPS) Growth is -11.49%
  • Net Margin is 8.16%
  • Current Asset to Current Liability Ratio is 1.8
  • Current Debt to Net Income Ratio is 11.04
  • Cash from Operations Growth is 6.24%
  • Investment Risk is High

What changed

Score by quarter

Downgraded from Hold to Sell in the Sep 2025 quarter: 54.2 → 47.5 (-6.7). This quarter: +2.3.

405060Oct 2022Jul 2026

What the score is made of

Income statement40.1 -0.2
Balance sheet46.0 +0.0
Cash flow50.3 +15.4

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)2.91 Billion4.05 % growth
EPS2.08-11.49 % growth
Profit margin8.16 %Profit per $1 of sales
P-E ratio—Not available
Market cap12.70 BillionShares × price
Debt-equity ratio0.37Leverage
Dividend0.28Per share, annual
Next earnings2026-11-03BMO · EPS forecast $1.29
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About REVVITY, INC.

Exchange
NYSE

Similar stocks

Loading…